Latest news from the EMCDDA

The Reitox network: frequently asked questions

15.10.2019 - This information brochure has been produced by the EMCDDA to provide answers to the most commonly asked questions on the Reitox network of national focal points and more broadly on national drugs observatories. It is a reference tool for both EU Member States and countries further afield on the network, its members, its role and development

spacer3.jpg

Developments in the European cannabis market

25.06.2019 - Cannabis products have become increasingly diverse in Europe. This report report explores the issues that it raises.

Laura d’Arrigo reelected as EMCDDA's Chair

14.12.2018 - The EU agency's Management Board held elections for the positions of Chair and Vice-Chair of the Board.

 

 

 

 

Quick access to the EMCDDA main publications archives

 Databases


minilogoOFDT.jpg

The OFDT provides an online bibliographic database on addiction.

 
Books3.jpg

The EMCDDA provides a database on their publications of interest.

 

 

 

 

 

Drugs in Europe


2019 EMCDDA European Drug Report

miniEDR2019s.jpgWhat do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.

  Country drug reports 2019

miniCountryProfiles.jpgDeveloped by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.